These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20449468)

  • 21. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syntheses, structures and properties of ruthenium complexes of tridentate ligands: isolation and characterization of a rare example of ruthenium nitrosyl complex containing {RuNO}5 moiety.
    Ghosh K; Kumar R; Kumar S; Meena JS
    Dalton Trans; 2013 Oct; 42(37):13444-52. PubMed ID: 23893046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure of cycloruthenated carbonyl complexes and their emission, redox and biological properties.
    Naresh Kumar K; Ramesh R; Liu Y
    J Inorg Biochem; 2006 Jan; 100(1):18-26. PubMed ID: 16310253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, spectral and catalytic dehydrogenation studies of ruthenium complexes containing NO bidentate ligands.
    Shoair AF; El-Bindary AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Oct; 131():490-6. PubMed ID: 24840490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterisation of ruthenium complexes containing a pendent catechol ring.
    O'Brien L; Duati M; Rau S; Guckian AL; Keyes TE; O'Boyle NM; Serr A; Görls H; Vos JG
    Dalton Trans; 2004 Feb; (4):514-22. PubMed ID: 15252512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, structure, and reactivity of new tetranuclear Ru-Hbpp-based water-oxidation catalysts.
    Francàs L; Sala X; Escudero-Adán E; Benet-Buchholz J; Escriche L; Llobet A
    Inorg Chem; 2011 Apr; 50(7):2771-81. PubMed ID: 21366245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
    Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
    Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varying electronic structural forms of ruthenium complexes of non-innocent 9,10-phenanthrenequinonoid ligands.
    Mandal A; Kundu T; Ehret F; Bubrin M; Mobin SM; Kaim W; Lahiri GK
    Dalton Trans; 2014 Feb; 43(6):2473-87. PubMed ID: 24306621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative cyclization of a phenolic Schiff base and synthesis of a cyclometalated ruthenium nitrosyl complex: photoinduced NO release by visible light.
    Ghosh K; Kumar S; Kumar R; Singh UP; Goel N
    Inorg Chem; 2010 Aug; 49(16):7235-7. PubMed ID: 20690733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innocence and noninnocence of the ligands in bis(pyrazine-2,3-dithiolate and -diselonate) d⁸-metal complexes. A theoretical and experimental study for the Cu(III), Au(III) and Ni(II) cases.
    Bruno G; Almeida M; Artizzu F; Dias JC; Mercuri ML; Pilia L; Rovira C; Ribas X; Serpe A; Deplano P
    Dalton Trans; 2010 May; 39(19):4566-74. PubMed ID: 20383385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structure, redox, NLO and DNA interaction aspects of [((L'-'")2RuII)3(mu3-L)]3+ and [(L')2RuII(NC5H4S-)]+[L3- = 1,3,5-triazine-2,4,6-trithiolato, L'-'" = arylazopyridine].
    Kar S; Pradhan B; Sinha RK; Kundu T; Kodgire P; Rao KK; Puranik VG; Lahiri GK
    Dalton Trans; 2004 Jun; (11):1752-60. PubMed ID: 15252573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
    Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation, reactivity, and photorelease of metal bound nitrosyl in [Ru(trpy)(L)(NO)](n+) (trpy = 2,2':6',2''-terpyridine, L = 2-phenylimidazo[4,5-f]1,10-phenanthroline).
    Maji S; Sarkar B; Patra M; Das AK; Mobin SM; Kaim W; Lahiri GK
    Inorg Chem; 2008 Apr; 47(8):3218-27. PubMed ID: 18311917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of N,C,N'- and C,N,N'-coordination modes on electronic and photophysical properties of cyclometalated aryl ruthenium(II) complexes.
    Wadman SH; Lutz M; Tooke DM; Spek AL; Hartl F; Havenith RW; van Klink GP; van Koten G
    Inorg Chem; 2009 Mar; 48(5):1887-900. PubMed ID: 19235952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The [Ru(Hedta)NO](0.1-) system: structure, chemical reactivity and biological assays.
    Zanichelli PG; Miotto AM; Estrela HF; Soares FR; Grassi-Kassisse DM; Spadari-Bratfisch RC; Castellano EE; Roncaroli F; Parise AR; Olabe JA; de Brito AR; Franco DW
    J Inorg Biochem; 2004 Nov; 98(11):1921-32. PubMed ID: 15522418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.
    Gianferrara T; Bratsos I; Iengo E; Milani B; Ostrić A; Spagnul C; Zangrando E; Alessio E
    Dalton Trans; 2009 Dec; (48):10742-56. PubMed ID: 20023904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors.
    Maiti BK; Görls H; Klobes O; Imhof W
    Dalton Trans; 2010 Jun; 39(24):5713-20. PubMed ID: 20495720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics and mechanism of NO production in the Ru(III)-(edta) mediated oxidation of L-arginine with H(2)O(2).
    Chatterjee D; Ghosh S; Pal U
    Dalton Trans; 2011 Jan; 40(3):683-5. PubMed ID: 21116580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Density functional theory calculations on ruthenium(IV) bis(amido) porphyrins: search for a broader perspective of heme protein compound II intermediates.
    Gonzalez E; Brothers PJ; Ghosh A
    J Phys Chem B; 2010 Nov; 114(46):15380-8. PubMed ID: 20979402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.